For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260311:nRSK1277Wa&default-theme=true
RNS Number : 1277W Itaconix PLC 11 March 2026
For release: 07:00, 11 March 2026
Itaconix plc
("Itaconix" or the "Company")
Notice of Results and Company Presentation
Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in high-performance
plant-based specialty polymers, announces that its Preliminary Results for the
year ended 31 December 2025 will be released on 24 March 2026.
Investor Meet Company presentation
A live presentation will be held on 25 March 2026 at 14:00 GMT. This
presentation is open to all interested parties. Anyone can sign up for free to
the Investor Meet Company platform and join the live presentation via:
https://www.investormeetcompany.com/itaconix-plc/register-investor
(https://www.investormeetcompany.com/itaconix-plc/register-investor)
Questions can be submitted pre-event via your Investor Meet Company dashboard
up until 24 March 2026, 09:00 GMT, or at any time during the live
presentation.
- Ends -
Itaconix plc +1 603 775-4400
John R. Shaw / Laura Denner
Rosewood +44 (0)20 7653 8702
John West / Llewellyn Angus / Lily Pearce
Canaccord Genuity - Nominated Adviser and Sole Broker +44 (0) 20 7523 8000
Adam James / Harry Pardoe
About Itaconix
Itaconix uses its proprietary plant-based polymer technology platform to
produce and sell specialty ingredients that improve the safety, performance,
and sustainability of consumer products. The Company's current ingredients are
enabling and leading new generations of cost-effective, decarbonized consumer
products in home and personal care.
www.itaconix.com (http://www.itaconix.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORAKKBDDBKBKND
Copyright 2019 Regulatory News Service, all rights reserved